Heart Disease Trial, Recruiting (NCT06625463)

Heart Disease Trial, Recruiting NCT06625463 Sponsor: Gadjah Mada University Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06625463 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with acute coronary syndrome (a serious heart condition), were admitted to hospital for it, and have been home for at least 3 months but no longer than 1 year since being discharged
People aged between 18 and 65 years old
People who are experiencing acute coronary syndrome for the first time, whether or not they had a procedure called PCI (a treatment to open blocked heart arteries) during their hospital stay
People who live with family members who are involved in helping care for them
People whose physical health is stable at the time of the interview — including normal blood pressure, heart rate, and temperature, and no current pain — and who do not show signs of depression based on a standard questionnaire called the PHQ-9
People who are willing to take part in the study

Who may not be able to join:

People who have other ongoing health conditions that require regular daily medication, such as diabetes, high blood pressure, or kidney failure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anggoro Budi Hartopo, PhD, Gadjah Mada University

Phone: +628963-6598-725

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06625463

Sponsor: Gadjah Mada University

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +628963-6598-725

More information: https://clinicaltrials.gov/study/NCT06625463

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with acute coronary syndrome (a serious heart condition), were admitted to hospital for it, and have been home for at least 3 months but no longer than 1 year since being discharged
People aged between 18 and 65 years old
People who are experiencing acute coronary syndrome for the first time, whether or not they had a procedure called PCI (a treatment to open blocked heart arteries) during their hospital stay
People who live with family members who are involved in helping care for them
People whose physical health is stable at the time of the interview — including normal blood pressure, heart rate, and temperature, and no current pain — and who do not show signs of depression based on a standard questionnaire called the PHQ-9
People who are willing to take part in the study

Who may not be able to join:

People who have other ongoing health conditions that require regular daily medication, such as diabetes, high blood pressure, or kidney failure

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Gadjah Mada University

Registry

ClinicalTrials.gov

Start date

1 January 2025

Est. completion

10 June 2025

Where this trial is recruiting

🇮🇩 Indonesia

Primary endpoints

health related quality of life; peak Vo2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov